MedTrace Logo

A Study for the Treatment of Diabetic Peripheral Neuropathic Pain

NCT00552175 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 339

Last updated 2010-04-13

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.

Conditions

  • Diabetic Neuropathies

Interventions

DRUG

Duloxetine hydrochloride - 40 mg

duloxetine 40 mg taken orally every day

DRUG

placebo

placebo taken orally every day

DRUG

Duloxetine hydrochloride - 60 mg

duloxetine 60 mg taken orally every day

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY(1-877-285-4559) OR 1-317-615-4559 Mon-Fri 9 AM-5 PM Eastern time (UTC/GMT-5 hours,EST) · Eli Lilly and Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00552175 on ClinicalTrials.gov